Jazz Pharmaceuticals plc
JAZZ
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic andā¦ read more
Healthcare
Biotechnology
17 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$117.77
Price+0.94%
$1.10
1Y
Price
Market Cap
$7.144b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years+19.5%
EBITDA Margin+16.5%
Net Profit Margin+25.4%
Free Cash Flow MarginRevenue
$4.087b
+2.0%
1y CAGR+8.3%
3y CAGR+14.0%
5y CAGREarnings
-$404.841m
-4.8%
1y CAGR+107.9%
3y CAGR+21.5%
5y CAGREPS
-$6.73
-8.2%
1y CAGR+102.7%
3y CAGR+19.4%
5y CAGRBook Value
$3.706b
$10.944b
Assets$7.238b
Liabilities$5.433b
DebtDebt to Assets
49.6%
5.1x
Debt to EBITDAFree Cash Flow
$1.265b
-5.3%
1y CAGR+12.8%
3y CAGR+19.8%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company